Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04111627 · ClinicalTrials.gov registry record · Phase 2
Exercise Plus Duloxetine for Knee Osteoarthritis
A Phase 2 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
NCT04111627 is a Phase 2 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 43 participants.
The verdict
NCT04111627, a Phase 2 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
Study Summary
This study evaluates the addition of duloxetine to aerobic exercise in the treatment of symptomatic knee osteoarthritis and depressive symptoms in adults. All participants will receive the receive the treatment protocol, which will first be evaluated in terms of feasibility and then pilot tested.
Interventions
- DRUG Duloxetine
- BEHAVIORAL Aerobic exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2021-10-07 |
| Est. Completion | 2025-08-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04111627
The ClinicalTrials.gov registry entry for NCT04111627 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Duloxetine is the first listed.
NCT04111627 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04111627 about?
NCT04111627 is a clinical study titled "Exercise Plus Duloxetine for Knee Osteoarthritis". This study evaluates the addition of duloxetine to aerobic exercise in the treatment of symptomatic knee osteoarthritis and depressive symptoms in adults. All participants will receive the receive the treatment protocol, which will first be evaluated in terms of feasibility and then pilot tested.
What is the current status of trial NCT04111627?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2021-10-07. Estimated completion is 2025-08-11.
What interventions are being tested in trial NCT04111627?
The interventions under investigation include: Duloxetine (DRUG), Aerobic exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT04111627?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.